StonvexLoading…
StonvexStonvexStonvexCore line items from FGNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.41M | $779.00K | $17.09M | $20.09M |
Operating Income | $-64.00M | $-11.71M | $-16.29M | $1.09M |
Net Income | $-66.74M | $-1.31M | $-14.64M | $1.09M |
EPS (Diluted) | $-25.69 | $-12.16 | $-35.22 | $-0.09 |
Total Assets | $163.84M | $109.47M | $62.14M | $49.48M |
Total Liabilities | $20.35M | $35.27M | $25.14M | $12.18M |
Cash & Equivalents | $13.39M | $6.56M | $6.00M | $3.01M |
Free Cash Flow OCF − CapEx | Not available | $-4.29M | $-8.00K | $-11.10M |
Shares Outstanding | 7.08M | 253.58K | 900.11K | 9.41M |